When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KRYS - Krystal Biotech up 27% on positive KB103 data in rare skin disorder
Krystal Biotech Inc.
Thinly traded Krystal Biotech (KRYS+26.8%) is up on more than triple normal volume, albeit on turnover of only 370K shares, on the heels of positive data from a Phase 2 clinical trial, GEM-2, evaluating topical gene therapy candidate KR103 in patients with a rare inherited skin disorder called dystrophic epidermolysis bullosa (DEB).
More news on: Krystal Biotech, Inc., Healthcare stocks news, Stocks on the move,